383 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Uptrend
Article Searches
Fundsmith Equity Fund Annual Letter To Shareholders 2018 https://seekingalpha.com/article/4234913-fundsmith-equity-fund-annual-letter-shareholders-2018?source=feed Jan 23, 2019 -
Retirement: 2018 Performance Of The Future-Proof Portfolio For Young Investors https://seekingalpha.com/article/4234427-retirement-2018-performance-future-proof-portfolio-young-investors?source=feed_all_articles Jan 20, 2019 -
J&J raises US prices on around two dozen drugs https://www.cnbc.com/2019/01/11/jj-raises-us-prices-on-around-two-dozen-drugs.html Jan 11, 2019 - Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.
What The Celgene Deal Means For The Biotech Sector https://seekingalpha.com/article/4231701-celgene-deal-means-biotech-sector?source=feed_sector_healthcare Jan 07, 2019 - On Jan. 3, pharma giant Bristol-Myers Squibb announced its intention to acquire Celgene, one of the largest biotech companies in the world, for $74 billion; the deal awaits shareholder approval.The bu
Story Starting To Change For AEterna Zentaris https://seekingalpha.com/article/4231159-story-starting-change-aeterna-zentaris?source=feed_sector_healthcare Jan 03, 2019 - It has been a long road for AEterna Zentaris and their AGHD testing drug Macrilen. But management has been executing the correct moves to get the product to market.Strongbridge sold their U.S. and Can
The New Generex: Unlocking The Value https://seekingalpha.com/article/4228973-new-generex-unlocking-value?source=feed_sector_healthcare Dec 18, 2018 - Merck collaboration on Phase II cancer trial against triple negative breast cancer and Shenzhen collaboration for Phase II cancer trial against prostate cancer.Buccal delivery system for insulin insid
Vanguard Health Care: A Good Place To Invest For The Future https://seekingalpha.com/article/4226233-vanguard-health-care-good-place-invest-future?source=feed_sector_healthcare Dec 04, 2018 - The increasing prevalence of a few diseases has caused the life expectancy in the United States to decline for the third straight year.One of these diseases is diabetes, which is a chronic condition l
The Future-Proof Portfolio For Young Investors: Stability In A Volatile Period https://seekingalpha.com/article/4223580-future-proof-portfolio-young-investors-stability-volatile-period?source=feed_all_articles Nov 20, 2018 - The portfolio had a very stable performance despite volatile markets, but currency exchange rates have had a big influence on this.Performance among sectors and stocks has proven to be very mixed.I wi
Novo Nordisk A/S (NVO) CEO Lars Fruergaard Jørgensen on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4217252-novo-nordisk-s-nvo-ceo-lars-fruergaard-jorgensen-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Nov 01, 2018 -
Novo Nordisk A/S 2018 Q3 - Results - Earnings Call Slides https://seekingalpha.com/article/4216942-novo-nordisk-s-2018-q3-results-earnings-call-slides?source=feed_sector_healthcare Nov 01, 2018 - The following slide deck was published by Novo Nordisk A/S in conjunction with their 2018 Q3 earnings call.

Pages: 1234567...39

<Page 2>